GNOS-PV02

· Geneos Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNOS-PV02, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC [Phase 1, Phase 2]

See pricing